Literature DB >> 28939628

Standardisation of the detection of germinal centres in salivary gland biopsies of patients with primary Sjögren's syndrome is needed to assess their clinical relevance.

Erlin A Haacke1,2, Bert van der Vegt2, Arjan Vissink3, Frederik K L Spijkervet3, Hendrika Bootsma1, Frans G M Kroese1.   

Abstract

Entities:  

Keywords:  MALT lymphoma; Sjögren’s syndrome; germinal centers; non-Hodgkin lymphoma; salivary gland biopsies

Mesh：

Year:  2017        PMID： 28939628     DOI： 10.1136/annrheumdis-2017-212164

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome.

Authors:  Alessia Alunno; Maria Comasia Leone; Roberto Giacomelli; Roberto Gerli; Francesco Carubbi
Journal:  Front Med (Lausanne)       Date:  2018-04-13

2.  Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor.

Authors:  Sarah Pringle; Bert van der Vegt; Xiaoyan Wang; Nico van Bakelen; T Jeroen N Hiltermann; Fred K L Spijkervet; Arjan Vissink; Frans G M Kroese; Hendrika Bootsma
Journal:  Front Oncol       Date:  2020-04-02       Impact factor: 6.244

3.  Bcl6 for identification of germinal centres in salivary gland biopsies in primary Sjögren's syndrome.

Authors:  Uzma Nakshbandi; Erlin A Haacke; Hendrika Bootsma; Arjan Vissink; Fred K L Spijkervet; Bert van der Vegt; Frans G M Kroese
Journal:  Oral Dis       Date:  2020-01-28       Impact factor: 3.511

4.  Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands.

Authors:  Francesco Carubbi; Alessia Alunno; Paola Cipriani; Gino Coletti; Barbara Bigerna; Mirko Manetti; Paola Di Benedetto; Onelia Bistoni; Gianluca Cipolloni; Vasiliki Liakouli; Piero Ruscitti; Elena Bartoloni; Roberto Giacomelli; Roberto Gerli
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.